glp-1 antagonists Receptor Agonists GLP-1 Agonists and Antagonists |

Preliminary Evidence of an Association Between ADHD Medications and Diminished Bone Health in Children and Adolescents

Louis Paul Joyce Head of the Translational Nanomedicine & Biotherapeutics Group and Senior Research Fellow, Adelaide University Lauren Ball Professor of Community Health and Wellbeing, The University of Queensland Emily Burch Accredited Practising Dietitian and Lecturer, Southern Cross University Sebastian Furness ARC Future Fellow, School of Biomedical Sciences, The University of Queensland Stuart Phillips Professor, Kinesiology, Tier 1 Canada Research Chair in Skeletal Muscle Health, McMaster University Oliver Hamer Postdoctoral Research Fellow, Edge Hill University Ana Santos Rutschman Professor of Law, Villanova University Shalini Arunogiri Addiction Psychiatrist, Associate Professor, Monash University Rachel Woods Associate Professor, University of Nottingham

What's the best creatine supplement for someone new to creatine

The GLP-1 boom was built on speed, not science regulatory gaps, DTC playbooks, and cash-pay demand

Men and women of different ages are exploring peptides for a variety of reasons, including recovery, energy, cognitive performance, sleep, metabolic health, and longevity

Our research findings suggested that SLC7A11, HMOX1, G6PD, RRM2, KIF20A, HELLS, GPT2, GLS2, SPP1, CCR2, DCN, IRS1, and IGF1 may play significant roles in HBV-ALF, and there were notable changes in the immune microenvironment in HBV-ALF